In a decision with far-reaching implications for trade secret and licensing disputes, the U.S. Court of Appeals for the Federal Circuit has reinstated $82.2 million of a $104.6…
In a decision with far-reaching implications for trade secret and licensing disputes, the U.S. Court of Appeals for the Federal Circuit has reinstated $82.2 million of a $104.6 million verdict that Versata Software previously secured against Ford Motor Company. The reinstated portion stems from Ford's breach of a licensing contract, and the court's ruling reaffirms the strength of contract-based damages awards in complex commercial litigation involving software and intellectual property.
Equally significant, the Federal Circuit revived an unjust enrichment damages theory that the district court had rejected, sending the trade secret misappropriation damages issue back to the lower court for a new trial. The decision signals that plaintiffs in trade secret cases may pursue recovery measured by the benefit the accused party obtained through misappropriation, in addition to more traditional damages frameworks such as lost profits or reasonable royalties. By restoring this avenue, the court has expanded the practical toolkit available to trade secret owners seeking meaningful redress.
For companies that license proprietary technology or rely on trade secret protections, the ruling underscores the importance of carefully drafted licensing agreements and disciplined contractual compliance. The reinstated contract damages reflect a willingness by appellate courts to enforce the bargained-for terms of complex commercial licenses, even where the underlying sums are substantial. Defendants accused of overstepping the scope of a license should expect rigorous judicial scrutiny of both the contract terms and the resulting economic harm.
On the trade secret side, the revival of an unjust enrichment theory is likely to shape litigation strategy on both sides of the docket. Plaintiffs will have additional latitude to frame damages around the defendant's gains, which may be considerable in cases involving competitive advantages, accelerated product development, or avoided licensing costs. Defendants, in turn, face heightened exposure and should reassess risk profiles in pending or anticipated disputes, as well as internal compliance protocols governing access to third-party confidential information.
This decision is poised to influence damages calculations and settlement dynamics across the trade secret landscape for years to come, and companies operating in technology-intensive industries should review their licensing and IP risk management practices accordingly.
This article is provided for general informational purposes and does not constitute legal advice. Clients facing specific licensing, trade secret, or damages questions should consult counsel for tailored guidance.